Department of Anesthesiology, American University of Beirut Medical Center, Beirut, Lebanon.
American University of Beirut, Beirut, Lebanon.
Minerva Anestesiol. 2024 Jan-Feb;90(1-2):31-40. doi: 10.23736/S0375-9393.23.17542-0. Epub 2023 Nov 21.
Few studies investigated the use of nefopam for pain control after laparoscopic cholecystectomy in the context of multimodal analgesia. The aim of this study was to evaluate the effect of adding nefopam to ketoprofen and acetaminophen given before the end of laparoscopic cholecystectomy.
In this double-blind, controlled study, 90 patients undergoing laparoscopic cholecystectomy during sevoflurane-dexmedetomidine-based anesthesia were randomized to receive either ketoprofen and acetaminophen or nefopam, ketoprofen, and acetaminophen for postoperative pain control before the end of surgery. The primary outcome was total morphine consumption in the Postanesthesia Care Unit (PACU).
PACU morphine consumption was significantly lower in the experimental group compared to the control group (0.9±1.8 mg vs. 2.3±2.4 mg, respectively; P=0.004, Cohen's d=0.63). In the experimental group, a smaller proportion of patients received morphine in PACU (24% vs. 60%, respectively; P=0.001), morphine during the first 24 hours after surgery (47% vs. 77%, respectively; P=0.004), and acetaminophen on the floor (76% vs. 93%, respectively; P=0.039) compared with the control group. The average pain score during PACU stay was also significantly lower in the experimental group (1.7±2.0 vs. 2.7±2.0, P=0.01). Median time to first morphine requirement (44.0 minutes, 95% CI [(31.96 to, 52.21)] was shorter in the control group than in the experimental group (higher than the 90 minutes-last time point taken in PACU).
Adding nefopam to ketoprofen and acetaminophen before the end of laparoscopic cholecystectomy provides a reduction in morphine consumption with superior analgesia in PACU.
很少有研究在多模式镇痛的背景下调查在腹腔镜胆囊切除术后使用奈福泮控制疼痛。本研究的目的是评估在手术结束前给予奈福泮、酮洛芬和对乙酰氨基酚对腹腔镜胆囊切除术后疼痛的影响。
在这项双盲、对照研究中,90 名在七氟醚-右美托咪定麻醉下接受腹腔镜胆囊切除术的患者被随机分为接受酮洛芬和对乙酰氨基酚或奈福泮、酮洛芬和对乙酰氨基酚用于手术结束前的术后疼痛控制。主要结局是术后恢复室(PACU)的总吗啡消耗量。
实验组 PACU 吗啡消耗量明显低于对照组(分别为 0.9±1.8 mg 和 2.3±2.4 mg;P=0.004,Cohen's d=0.63)。实验组在 PACU 中接受吗啡的患者比例较小(分别为 24%和 60%;P=0.001),术后 24 小时内接受吗啡的患者比例较小(分别为 47%和 77%;P=0.004),在地板上接受对乙酰氨基酚的患者比例较小(分别为 76%和 93%;P=0.039)与对照组相比。实验组在 PACU 停留期间的平均疼痛评分也明显较低(1.7±2.0 与 2.7±2.0,P=0.01)。对照组首次需要吗啡的中位时间(44.0 分钟,95%CI[(31.96 至,52.21)])短于实验组(高于 PACU 中的最后一次时间点)。
在腹腔镜胆囊切除术前添加奈福泮、酮洛芬和对乙酰氨基酚可减少吗啡的消耗,并在 PACU 中提供更好的镇痛效果。